What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
Albensi BC. · 2019
Read What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? by Albensi BC. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6692429.txt.
Introduction
Albensi asks what nuclear factor kappa B is doing in and to the mitochondrion. His review appears in Frontiers in Cell and Developmental Biology. NF-κB signalling is famous for immunity and inflammation. Its mitochondrial life is far less charted. Subunits were first reported inside mitochondria in 2001. Pathway kinases were found there too. Follow-up work has stayed scattered since. Inside, the factor may regulate oxidative phosphorylation genes. It may switch cells between glycolysis and respiration. Apoptotic signalling also seems involved.
Influence flows from outside as well. Nuclear NF-κB shapes mitochondrial gene expression indirectly. Import mechanisms remain genuinely unclear, though. No defined targeting sequence explains the localisation. The author flags the speculation openly. More proof is the field's need.
Catalog record
| CREATOR | Albensi BC. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? By Benedict C Albensi Published in: Frontiers in Cell and Developmental Biology DOI: 10.3389/fcell.2019.00154 ABSTRACT Abstract A large body of literature supports the idea that nuclear factor kappa B (NF-κB) signaling contributes to not only immunity, but also inflammation, cancer, and nervous system function. However, studies on NF-κB activity in mitochondrial function are much more limited and scattered throughout the literature. For example, in 2001 it was first published that NF-κB subunits were found in the mitochondria, including not only IkBα and NF-κB p65 subunits, but also NF-κB pathway proteins such as IKKα, IKKβ, and IKKγ, but not much follow-up work has been done to date. Upon further thought the lack of studies on NF-κB activity in mitochondrial function is surprising given the importance and the evolutionary history of both NF-κB and the mitochondrion. Both are ancient in their appearance in our biological record where both contribute substantially to cell survival, cell death, and the regulation of function and/or disease. Studies also show NF-κB can influence mitochondrial function from outside the mitochondria. Therefore, it is essential to understand the complexity of these roles both inside and out of this organelle. In this review, an attempt is made to understand how NF-κB activity contributes to overall mitochondrial function – both inside and out. The discussion at times is speculative and perhaps even provocative to some, since NF-κB does not yet have defined mitochondrial targeting sequences for some nuclear-encoded mitochondrial genes and mechanisms of mitochondrial import for NF-κB are not yet entirely understood. Also, the data associated with the mitochondrial localization of proteins must be yet further proved with additional experiments. Keywords: inflammation, immunity, mitochondria, cancer, Alzheimer’s, nervous system INTRODUCTION Nuclear factor kappa B (NF-κB) is an ancient protein transcription factor (Salminen et al., 2008) and considered a regulator of innate immunity (Baltimore, 2009). The NF-κB signaling pathway links pathogenic signals and cellular danger signals thus organizing cellular resistance to invading pathogens. In fact, a plethora of studies have shown NF-κB is a network hub responsible for complex biological signaling (Albensi and Mattson, 2000; Kaltschmidt and Kaltschmidt, 2009; Karin, 2009). To this end, NF-κB has been hypothesized to be a master regulator of evolutionarily conserved biochemical cascades (Mattson et al., 2000). Other factors are also translocated into the mitochondria and are involved in modulating expression (Barshad et al., 2018a), but are not the focus of this review. The purpose of this review is to attempt to understand how NF-κB activity contributes to mitochondrial function. It is assumed the reader already has an understanding of basic mitochondrial biology. In the case of further study, the reader is referred to many excellent studies and reviews on mitochondrial structure and function (Hall, 1979; Fox, 1982; Roger and Silberman, 2002; Henze and Martin, 2003; Conradt, 2006; Ettema, 2016; Wang and Youle, 2016; Barshad et al., 2018b). NF-ΚB ACTIVATION Nuclear factor kappa B subunits, comprising the NF-κB complex, are expressed in both neurons and glia. The NF-κB complex exists in an inactive state in the cytoplasm (Ghosh et al., 1998; Aggarwal et al., 2004; Hayden and Ghosh, 2004) where the activation of NF-κB has been well described (Li and Karin, 2000; Baud and Jacque, 2008; Israel, 2010). When stimulated by molecules such as TNFα, or other cell stressors, TNFα binds to TNF receptors (Figure 1). This binding, via several intermediate steps, leads to an interaction with the IκB kinase (IKK) complex, which then leads to the phosphorylation of IκB, and subsequently results in IκB ubiquitination and degradation. Once degraded, the remaining NF-κB dimer (e.g., p65/p50 subunits) translocates to the nucleus, where it binds to the DNA consensus sequence of various target genes. The selectivity of the NF-κB response is based on several factors (Sen and Smale, 2010) including dimer composition, timing, and cell type. NF-κB’s influence on cell survival is also complex and can be neuroprotective or proinflammatory, depending on cell type, developmental stage, and pathological state (Qin et al., 2007). [Figure: Pathways for Nuclear factor κ B (NF-κB) signaling in the cytoplasm and the mitochondrion. The NF-κB tri-subunt complex (e.g., p65, p50, IκB – one possible combination) exists in an inactive state in the cytoplasm. NF-κB activation is initiated when molecules such as TNFα bind to TNF receptors (different types exist). Other external or internal stimuli can also activate NF-κB. A complicated signal transduction process then begins once TNF receptors are activated; IκB kinase (IKK) is ultimately triggered and leads to the phosphorylation of IκB, which results in IκB ubiquitination and degradation. Once IκB is degraded, the remaining NF-κB dimer (e.g., p65/p50 or p50/p50 subunit combinations are possible) translocates to the nucleus, where it binds to a DNA consensus sequence of target genes. By processes not well understood, the NF-κB complex or NF-κB subunits can also migrate into the mitochondrion, where evidence suggests it/they occupies the intermembrane space. Once inside the mitochondria, NF-κB is thought to interact with OXPHOS genes (mitochondrial mtDNA) that leads to the expression of proteins involved in various functions, including mitochondrial dynamics and COX III regulation (component of Complex IV). Evidence also suggests, NF-κB can function as a switch in the mitochondria and control the balance between the utilization of cytoplasmic glycolysis and mitochondrial respiration in normal cells and in cancer. Finally, data also point to intrinsic apoptotic pathway stimulation, where NF-κB activation in the mitochondria leads to cytochrome c release, thus triggering caspase cascades and programed cell death.] Organizationally, NF-κB is a Rel family transcription factor and is associated with five genes, NF-κB1, NF-κB2, RELA, RELB, and REL (Chen and Greene, 2004); these genes encode several proteins, NF-κB1, NF-κB2, RelA, RelB, and c-Rel, respectively, where two of these proteins are large precursor proteins known as p105 and p100 that undergo proteolysis to become p50 and p52, respectively. These proteins contain REL-homology domains (RHD) at their amino-terminal region; the RHD region is composed of 2 separate, but adjoining domains. The sequence most distant from the carboxy-terminal region allows the protein to bind to DNA. A more interior sequence allows the Rel family proteins to dimerize (homo- or heterodimers) for the suppression of expression via the binding of their corresponding family of inhibitors, the IκB proteins (Chen and Greene, 2004). The latter sequence includes the nuclear-localization sequence (NLS) that becomes unmasked when IκB is unbound by degradation. The NLS has the job of guiding or tagging active proteins for import into the cell nucleus (Chen and Greene, 2004; Karin et al., 2004; Barger et al., 2005). Three of these proteins (RelA, RelB, and c-REL) also encode a transactivation domain (TADs) in their carboxy-terminal region. The TADs allow these proteins to interact with the basal transcription apparatus, known as the TATA binding protein (TBP), Transcription Factor IIB, as well as the p300 and cAMP response element (CREB) binding protein (CBP) transcriptional co-activators (Chen and Greene, 2004). Only these three proteins are able to induce transcription of their DNA-coding regions while the other proteins, the p50 and p52 homodimers, are able to occupy the DNA binding sites without initiating transcription. Given this, the later 2 homodimers proteins of p50 and p52 act as transcriptional repressors (Chen and Greene, 2004). The p105 and